A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.
Clinical trial NCT06085924 · COMPLETED
Trial details
- NCT number
- NCT06085924
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-07
- Primary completion
- 2025-02-28
- Enrollment
- 2315187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.